First Time Loading...

Entera Bio Ltd
NASDAQ:ENTX

Watchlist Manager
Entera Bio Ltd Logo
Entera Bio Ltd
NASDAQ:ENTX
Watchlist
Price: 1.98 USD -1% Market Closed
Updated: Apr 29, 2024

Entera Bio Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Entera Bio Ltd
Net Income (Common) Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Entera Bio Ltd
NASDAQ:ENTX
Net Income (Common)
-$8.9m
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Net Income (Common)
-$7m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Net Income (Common)
$8.3m
CAGR 3-Years
-21%
CAGR 5-Years
-18%
CAGR 10-Years
34%
B
BioLine RX Ltd
TASE:BLRX
Net Income (Common)
-$60.6m
CAGR 3-Years
-26%
CAGR 5-Years
-21%
CAGR 10-Years
-14%
Urogen Pharma Ltd
NASDAQ:URGN
Net Income (Common)
-$102.2m
CAGR 3-Years
7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Net Income (Common)
-₪31m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-12%

See Also

What is Entera Bio Ltd's Net Income (Common)?
Net Income (Common)
-8.9m USD

Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Net Income (Common) amounts to -8.9m USD.

What is Entera Bio Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
3%

Over the last year, the Net Income (Common) growth was 32%. The average annual Net Income (Common) growth rates for Entera Bio Ltd have been 7% over the past three years , 3% over the past five years .